Results 191 to 200 of about 42,692 (257)

Essential Tremor Cases with Subtle Cerebellar Pathology: A Systematic Study of Postmortem Cerebellar Changes. [PDF]

Cerebellum
Betzios SI, Hernandez RS, Faust PL, Louis ED.   +3 more
europepmc   +1 more source

A homozygous missense variant, p.Ser166Leu in the <i>PRPF40B</i> gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor. [PDF]

Front Neurol
Onat OE, Sonti S, Robakis D, Tekinay AB, Akbostanci C, Durmaz Celik FN, Ozcelik T, Clark LN.   +7 more
europepmc   +1 more source

Genetic and Pathological Testing Attitudes for Parkinson's Disease in At‐Risk Relatives

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is increasingly recognized as a neurodegenerative disorder with a broad clinical spectrum and diverse biomarkers enabling early detection. α‐synuclein seed amplification assays (SAA) and genetic testing now allow identification of PD pathology in asymptomatic individuals.
Tal Weil, Anat Mirelman, Roy N. Alcalay, Nurit Omer, Penina Ponger, Avner Thaler   +5 more
wiley   +1 more source

Intention Tremor Severity Trajectory: Results from a Prospective Longitudinal Study of Essential Tremor. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Louis ED, Berry DS, Hernandez NC, Wainman E, Carter ED, Sharma VD.   +5 more
europepmc   +1 more source

Prevalence and Impact of Probable REM Sleep Behavior Disorder in Essential Tremor: A Multicenter Cross-Sectional Study. [PDF]

Eur J Neurol
Wang Y, Li M, He R, Duan X, Jin L, Chang D, JuanWan, Jiang M, Wu J, Cai M, Zeng S, Yuan M, Wu H, Wang C, Zhao G, Sun Q, Tang B, China Essential Tremor Alliance.   +17 more
europepmc   +1 more source

Quantitative Assessment of Visible Nigrosome‐1 in Patients with Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The nigrosome‐1 (N1) sign on susceptibility‐weighted imaging (SWI) typically disappears in Parkinson's disease (PD), though some patients can show uni−/bilaterally preserved N1. Objective Investigating whether visible nigrosomes in PD patients differ from those of healthy subjects (HC). Methods Forty‐eight PD and 35 HC underwent 3 T‐
Maria Eugenia Caligiuri, Ilaria Chimento, Marida De Maria, Emma Biondetti, Jolanda Buonocore, Valerio Riccardo Aquila, Maria Celeste Bonacci, Emanuele Tinelli, Umberto Sabatini, Aldo Quattrone, Andrea Quattrone   +10 more
wiley   +1 more source

Comparative study of the pathology in anterior versus posterior hemispheric regions of cerebellum in essential tremor and controls. [PDF]

Acta Neuropathol
Musacchio-Perrucci JB, Martuscello RT, Betzios SI, Hernandez RS, Kuo SH, Cosentino S, Fujita H, Louis ED, Faust PL.   +8 more
europepmc   +1 more source

Resolution of Levodopa/Dopa‐Decarboxylase Inhibitor—Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Microscopic colitis (MC) typically presents with chronic, non‐bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa‐decarboxylase inhibitor (LDDCI) therapy.
Romana Hintner, Franziska Eberhardt, Manuela Kofler, Andreas Eigentler, Atbin Djamshidian, Florian Krismer, Anton Hittmair, Heinz Zoller, Valentina Ellinger, Beatrice Heim, Klaus Seppi   +10 more
wiley   +1 more source

Diagnostic performance of essential tremor criteria in electronic health records: a retrospective neurology cohort study. [PDF]

Front Neurol
Swackhamer HP, Stoica S, Sapkota M, Olulana OI, Taye M, Patel AC, Smith AM, Mian IC, Gupta M, Stanciu AC, Sandulescu MC.   +10 more
europepmc   +1 more source

Risk‐Benefit Considerations in Deep Brain Stimulation Discontinuation for Late‐Stage Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Management of deep brain stimulation (DBS) in late‐stage Parkinson's disease (LSPD) remains challenging, particularly when deciding whether to continue or discontinue stimulation, and evidence on risk–benefit considerations is limited. Objectives To identify key factors to improve decision‐making in DBS management for LSPD patients.
Pietro Antenucci, Andrea Gozzi, Fabiana Colucci, Federica Pes, Jay Guido Capone, Alba Scerrati, Michele Alessandro Cavallo, Maura Pugliatti, Daniela Gragnaniello, Mariachiara Sensi   +9 more
wiley   +1 more source